Cure8

Why This Matters

Children with IBD are at higher risk for C. difficile and practices for diagnosing and treating CDI in pediatric IBD vary widely. Standardized, pediatric-specific guidance could reduce uncertainty and improve care.

Who Should Pay Attention

Pediatric IBD clinicians; parents and caregivers of children with IBD; pediatric gastroenterology centers; researchers focused on pediatric CDI.

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract

What To Know

This national survey summarizes current real-world practices across pediatric IBD centers in Italy and highlights inconsistent diagnostic approaches and treatment choices for CDI in children with IBD. It does not test treatments or provide outcomes data.

The findings show widespread use of multiple CDI tests and variation in first-line antibiotic selection; recurrent CDI is typically treated with oral vancomycin, and fidaxomicin, FMT, or bezlotoxumab are considered for multiple recurrences.

Management of immunosuppression during CDI varied, with many centers delaying or using a cautious approach to starting biologics in severe colitis with CDI. Implications are that pediatric-specific, evidence-based guidelines are needed to reduce variability and address gaps in diagnosis and management.

Keep In Mind

Results come from a 2025 nationwide survey of Italian pediatric IBD centers (27 centers). This is descriptive, self-reported data and does not contain trial outcomes or efficacy comparisons.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationJournal of pediatric gastroenterology and nutrition
AuthorsAnastasiia Romanchuk, Matteo Bramuzzo, Flavio Labriola +28 more
InstitutionPaediatric Hepatology Gastroenterology and Transplantation, Hospital Papa Giovanni XXIII, Bergamo, Italy.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedSep 17, 2026, 12:00 AM
Content availableJournal abstract

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →